Literature DB >> 25709813

HIV infection and osteoporosis.

Juliet Compston1.   

Abstract

In the past two decades, the life expectancy of people living with HIV infection has increased significantly, and osteoporosis has emerged as a significant comorbidity. In addition to traditional risk factors for fracture, specific factors related to HIV infection are also likely to contribute, including antiretroviral therapy. The heterogeneity of the HIV-infected population in terms of age and ethnicity presents many challenges to the prevention and management of bone disease, and further studies are required to establish optimal approaches to risk assessment and treatment.

Entities:  

Year:  2015        PMID: 25709813      PMCID: PMC4325555          DOI: 10.1038/bonekey.2015.3

Source DB:  PubMed          Journal:  Bonekey Rep        ISSN: 2047-6396


  54 in total

1.  Osteopenia in HIV-infected patients: is it the disease or is it the treatment?

Authors:  H Knobel; A Guelar; G Vallecillo; X Nogués; A Díez
Journal:  AIDS       Date:  2001-04-13       Impact factor: 4.177

Review 2.  Bone disease and HIV infection.

Authors:  Valerianna Amorosa; Pablo Tebas
Journal:  Clin Infect Dis       Date:  2005-11-30       Impact factor: 9.079

3.  Effects of a supervised home-based aerobic and progressive resistance training regimen in women infected with human immunodeficiency virus: a randomized trial.

Authors:  Sara E Dolan; Walter Frontera; Jamie Librizzi; Karin Ljungquist; Sandra Juan; Robert Dorman; Morgan E Cole; Jenna R Kanter; Steven Grinspoon
Journal:  Arch Intern Med       Date:  2006-06-12

4.  Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection.

Authors:  Julia H Arnsten; Ruth Freeman; Andrea A Howard; Michelle Floris-Moore; Yungtai Lo; Robert S Klein
Journal:  AIDS       Date:  2007-03-12       Impact factor: 4.177

5.  Effect of alendronate on HIV-associated osteoporosis: a randomized, double-blind, placebo-controlled, 96-week trial (ANRS 120).

Authors:  Sylvie Rozenberg; Emillie Lanoy; Michelle Bentata; Jean-Paul Viard; Marc Antoine Valantin; Pascale Missy; Iuliana Darasteanu; Christian Roux; Sami Kolta; Dominique Costagliola
Journal:  AIDS Res Hum Retroviruses       Date:  2012-03-23       Impact factor: 2.205

6.  A double-blinded, randomized controlled trial of zoledronate therapy for HIV-associated osteopenia and osteoporosis.

Authors:  Jeannie Huang; Linda Meixner; Susan Fernandez; J Allen McCutchan
Journal:  AIDS       Date:  2009-01-02       Impact factor: 4.177

7.  Continuous antiretroviral therapy decreases bone mineral density.

Authors:  Birgit Grund; Grace Peng; Cynthia L Gibert; Jennifer F Hoy; Rachel L Isaksson; Judith C Shlay; Esteban Martinez; Peter Reiss; Fehmida Visnegarwala; Andrew D Carr
Journal:  AIDS       Date:  2009-07-31       Impact factor: 4.177

8.  HIV infection and bone mineral density in middle-aged women.

Authors:  Julia H Arnsten; Ruth Freeman; Andrea A Howard; Michelle Floris-Moore; Nanette Santoro; Ellie E Schoenbaum
Journal:  Clin Infect Dis       Date:  2006-02-24       Impact factor: 9.079

9.  Trabecular and cortical microarchitecture in postmenopausal HIV-infected women.

Authors:  Michael T Yin; Aimee Shu; Chiyuan A Zhang; Stephanie Boutroy; Donald J McMahon; David C Ferris; Ivelisse Colon; Elizabeth Shane
Journal:  Calcif Tissue Int       Date:  2013-03-05       Impact factor: 4.333

10.  Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen.

Authors:  Todd T Brown; Grace A McComsey; Martin S King; Roula B Qaqish; Barry M Bernstein; Barbara A da Silva
Journal:  J Acquir Immune Defic Syndr       Date:  2009-08-15       Impact factor: 3.771

View more
  11 in total

1.  Sexual Minority Stress and Cellular Aging in Methamphetamine-Using Sexual Minority Men With Treated HIV.

Authors:  Delaram Ghanooni; Adam W Carrico; Renessa Williams; Tiffany R Glynn; Judith T Moskowitz; Savita Pahwa; Suresh Pallikkuth; Margaret E Roach; Samantha Dilworth; Bradley E Aouizerat; Annesa Flentje
Journal:  Psychosom Med       Date:  2022-08-16       Impact factor: 3.864

Review 2.  Bone Quality in Relation to HIV and Antiretroviral Drugs.

Authors:  Arnold Z Olali; Kelsey A Carpenter; Maria Myers; Anjali Sharma; Michael T Yin; Lena Al-Harthi; Ryan D Ross
Journal:  Curr HIV/AIDS Rep       Date:  2022-06-20       Impact factor: 5.495

3.  Bone Safety of Dolutegravir-Containing Regimens in People Living with HIV: Results from a Real-World Cohort.

Authors:  Paolo Bonfanti; Andrea De Vito; Elena Ricci; Barbara Menzaghi; Giancarlo Orofino; Nicola Squillace; Chiara Molteni; Giuseppe Vittorio De Socio; Elena Salomoni; Benedetto Maurizio Celesia; Chiara Dentone; Valeria Colombo; Giordano Madeddu
Journal:  Infect Drug Resist       Date:  2020-07-14       Impact factor: 4.003

Review 4.  Role of non-Genetic Risk Factors in Exacerbating Alcohol-related organ damage.

Authors:  Natalia A Osna; Rakesh Bhatia; Christopher Thompson; Surinder K Batra; Sushil Kumar; Yeonhee Cho; Gyongyi Szabo; Patricia E Molina; Steven A Weinman; Murali Ganesan; Kusum K Kharbanda
Journal:  Alcohol       Date:  2020-06-01       Impact factor: 2.405

5.  Higher Levels of Osteoprotegerin and Immune Activation/Immunosenescence Markers Are Correlated with Concomitant Bone and Endovascular Damage in HIV-Suppressed Patients.

Authors:  Alessandra D'Abramo; Maria Antonella Zingaropoli; Alessandra Oliva; Claudia D'Agostino; Samir Al Moghazi; Giulia De Luca; Marco Iannetta; Gabriella d'Ettorre; Maria Rosa Ciardi; Claudio Maria Mastroianni; Vincenzo Vullo
Journal:  PLoS One       Date:  2016-02-25       Impact factor: 3.240

Review 6.  Ageing with HIV.

Authors:  Padraig McGettrick; Elena Alvarez Barco; Patrick W G Mallon
Journal:  Healthcare (Basel)       Date:  2018-02-14

7.  The prevalence and risk of non-infectious comorbidities in HIV-infected and non-HIV infected men attending general practice in Australia.

Authors:  Jack Edward Heron; Sarah M Norman; Jeannie Yoo; Kirsty Lembke; Catherine C O'Connor; Clare E Weston; David M Gracey
Journal:  PLoS One       Date:  2019-10-09       Impact factor: 3.240

8.  The Adenosine A2A Receptor Agonist Accelerates Bone Healing and Adjusts Treg/Th17 Cell Balance through Interleukin 6.

Authors:  Xi Zheng; Dong Wang
Journal:  Biomed Res Int       Date:  2020-04-23       Impact factor: 3.411

9.  Change in Circulating Undercarboxylated Osteocalcin (ucOCN) Is Associated With Fat Accumulation in HIV-Seropositive Women.

Authors:  Arnold Z Olali; Anjali Sharma; Qiuhu Shi; Donald R Hoover; Kathleen M Weber; Audrey L French; Heather S McKay; Phyllis C Tien; Lena Al-Harthi; Michael T Yin; Ryan D Ross
Journal:  J Acquir Immune Defic Syndr       Date:  2021-04-15       Impact factor: 3.771

10.  Patterns of vitamin D, parathyroid hormone and c-terminal telopeptide of collagen type 1 in Caucasian and African descent HIV-infected populations in Central Europe.

Authors:  Sebastian Noe; Celia Oldenbuettel; Silke Heldwein; Hans Jaeger; Eva Wolf
Journal:  Infect Dis Rep       Date:  2017-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.